Fosters Research
No Result
View All Result
No Result
View All Result
Fosters Research
No Result
View All Result
Home Industry

Do you still think Arthur J. Gallagher & Co. (NYSE:AJG) is worth a look?

January 19, 2023
in Industry

In yesterday’s Wall Street session, Arthur J. Gallagher & Co. (NYSE:AJG) shares traded at $191.99, down -1.87% from the previous session.

As of this writing, 18 analysts cover Arthur J. Gallagher & Co. (NYSE:AJG). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $225.00 and a low of $144.00, we find $217.50. Given the previous closing price of $195.65, this indicates a potential upside of 11.17 percent. AJG stock price is now -0.03% away from the 50-day moving average and 8.07% away from the 200-day moving average. The market capitalization of the company currently stands at $40.16B.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored

There are 2 analysts who have given it a hold rating, whereas 13 have given it a buy rating. Brokers who have rated the stock have averaged $208.93 as their price target over the next twelve months.

With the price target maintained at $210, Keefe Bruyette recently Downgraded its rating from Outperform to Mkt Perform for Arthur J. Gallagher & Co. (NYSE: AJG). On December 15, 2022, Citigroup recently initiated its ‘Buy’ rating on the stock quoting a target price of $225, while ‘Piper Sandler’ rates the stock as ‘Neutral’.

In other news, McCurdy Kay W, Director sold 750 shares of the company’s stock on Dec 01. The stock was sold for $149,250 at an average price of $199.00. Upon completion of the transaction, the Director now directly owns 31,273 shares in the company, valued at $6.0 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 30, Director BARRAT SHERRY S sold 505 shares of the business’s stock. A total of $100,286 was realized by selling the stock at an average price of $198.59. This leaves the insider owning 21,613 shares of the company worth $4.15 million. Insiders disposed of 496,177 shares of company stock worth roughly $95.26 million over the past 1 year. A total of 0.30% of the company’s stock is owned by insiders.

There have been several recent changes in the stakes of large investors in AJG stock. A new stake in Arthur J. Gallagher & Co. shares was purchased by WCM INVESTMENT MANAGEMENT, LLC during the first quarter worth $489,018,000. CAPITAL WORLD INVESTORS invested $119,553,000 in shares of AJG during the first quarter. In the first quarter, INVESTMENT MANAGEMENT CORP OF ONTARIO acquired a new stake in Arthur J. Gallagher & Co. valued at approximately $57,597,000. T. ROWE PRICE INVESTMENT MANAGEMENT, INC. acquired a new stake in AJG for approximately $36,032,000. 11 CAPITAL PARTNERS LP purchased a new stake in AJG valued at around $12,700,000 in the second quarter. In total, there are 1,158 active investors with 87.20% ownership of the company’s stock.

Wednesday morning saw Arthur J. Gallagher & Co. (NYSE: AJG) opened at $195.24. During the past 12 months, Arthur J. Gallagher & Co. has had a low of $147.32 and a high of $201.51. As of last week, the company has a debt-to-equity ratio of 0.73, a current ratio of 1.10, and a quick ratio of 1.10. The fifty day moving average price for AJG is $192.05 and a two-hundred day moving average price translates $177.65 for the stock.

The latest earnings results from Arthur J. Gallagher & Co. (NYSE: AJG) was released for Sep, 2022. According to the Insurance Brokers Company, earnings per share came in at $1.72, beating analysts’ expectations of $1.66 by 0.06. This compares to $1.13 EPS in the same period last year. The net profit margin was 12.80% and return on equity was 12.50% for AJG. The company reported revenue of $2.04 billion for the quarter, compared to $2.14 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -4.41 percent. For the current quarter, analysts expect AJG to generate $1.96B in revenue.

Moreover, the firm recently paid out its quarterly dividend on 12/16/2022. Investors who held shares on 12/02/2022 were paid a $0.51 dividend. On an annualized basis, this represents a $2.04 dividend and a 1.06% percent yield. There was an ex-dividend date of 12/01/2022 for this dividend. In terms of dividend payout ratio, AJG is presently at 38.10%.

Arthur J. Gallagher & Co.(AJG) Company Profile

Arthur J. Gallagher & Co., together with its subsidiaries, provides insurance brokerage, consulting, third-party claims settlement, and administration services in the United States, Australia, Bermuda, Canada, the Caribbean, New Zealand, India, and the United Kingdom. It operates through Brokerage and Risk Management segments. The Brokerage segment consists of retail and wholesale insurance brokerage operations; assists retail brokers and other non-affiliated brokers in the placement of specialized and hard-to-place insurance; acts as a brokerage wholesaler, managing general agent, and managing general underwriter for distributing specialized insurance coverage’s to underwriting enterprises. This segment also performs activities, including marketing, underwriting, issuing policies, collecting premiums, appointing and supervising other agents, paying claims, and negotiating reinsurance; and offers brokerage and consulting services to businesses and organizations, including commercial, not-for-profit, and public entities, as well as individuals in the areas of insurance placement, risk of loss management, and management of employer sponsored benefit programs. The Risk Management segment provides contract claim settlement and administration services to enterprises and public entities; and claims management, loss control consulting, and insurance property appraisal services. The company offers its services through a network of correspondent insurance brokers and consultants. It serves commercial, industrial, public, religious, and not-for-profit entities. The company was incorporated in 1927 and is headquartered in Rolling Meadows, Illinois.

Tags: AJGAJG stockArthur J. Gallagher & Co.NYSE:AJG

Related Posts

Can Titan Pharmaceuticals Inc. (TTNP) stock recover despite sales dropping?

January 27, 2023

Investor Insight: OneWater Marine Inc. (ONEW) Goes Ballistic – Investor Confidence on the Rise

January 27, 2023

When is the right time to cash out of Matthews International Corporation [MATW] stock?

January 27, 2023

Is Atreca Inc. [BCEL] a good investment? Don’t be fooled by its recent momentum

January 27, 2023

The most important numbers to know about Ascent Solar Technologies Inc. (NASDAQ:ASTI)

January 27, 2023

Before You Invest In Harte Hanks Inc. (NASDAQ:HHS), Consider This Metric

January 27, 2023
Next Post

There's Still Time to Buy Prometheus Biosciences Inc. (NASDAQ:RXDX) Stock

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

There is little time left for Roblox Corporation (RBLX) to reach its 1-year target estimate. How soon will it surpass it?

2 months ago

A Stock With Stellar Fundamentals? Garmin Ltd. (NYSE:GRMN): Is It Right For You?

2 weeks ago

Stocks of Eaton Vance California Municipal Bond Fund [EVM] are gaining investors’ attention: here’s why

2 months ago

The most important numbers to know about Airbnb Inc. (NASDAQ:ABNB)

2 months ago
logo

Welcome to Fosters Research.
We provide quality information for free in a convenient place and format. You do not need to look for us – the news portal “Fosters Research” meets the reader every morning.

Categories

  • Analyst Opinions
  • Featured
  • Finance
  • Market News
  • Technical Indicators
  • Trending Stocks

Company

  • Home
  • About us
  • Contact

Recent Posts

  • Can Titan Pharmaceuticals Inc. (TTNP) stock recover despite sales dropping?
  • There is little time left for S&T Bancorp Inc. (STBA) to reach its 1-year target estimate. How soon will it surpass it?

Copyright © 2022 fostersresearch

No Result
View All Result
  • Home
  • Analyst Opinions
  • Market News
  • Technical Indicators
  • Trending Stocks

Copyright © 2022 fostersresearch